Related Experiment Video

Updated: Aug 31, 2026

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

Excellent response to steroid treatment in anti-GAD cerebellar ataxia

Giuseppe Lauria1, Davide Pareyson, Maria Giuseppina Pitzolu

  • 1Department of Clinical Neurosciences, University of Brescia, Italy. g_lauria@libero.it

The Lancet. Neurology
|September 25, 2003
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

Related Experiment Videos

Last Updated: Aug 31, 2026

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Articles linked to this work by shared authors, journal, and citation graph.

Biallelic PIGB Variants Cause Motor Neuropathy with Conduction Blocks and Peripheral Nerve Hyperexcitability.

Annals of neurology·2026

Patient-Reported Complications and Outcomes of General, Central Neuraxial, and Peripheral Regional Anesthesia in Charcot-Marie-Tooth Disease.

Neurology. Genetics·2026

Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy: Systematic Review and Network Meta-Analysis.

European journal of neurology·2026

A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis.

Journal of the peripheral nervous system : JPNS·2026

ChatGPT in the diagnosis and management of complex polyneuropathies: comparative analysis with neurologists using real-world cases.

NPJ digital medicine·2026

Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly).

European journal of neurology·2026

Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study.

The Lancet. Neurology·2026

Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies.

The Lancet. Neurology·2026

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.

The Lancet. Neurology·2026

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.

The Lancet. Neurology·2026

Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.

The Lancet. Neurology·2026

Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Neurology·2026

The Metabolites of Secoiridoid Enantiomers and Diastereomers with 9-Carbon Skeleton in Gentiana macrophylla Pall.

Current drug metabolism·2026

A systematic review of structure-activity relationships in bacterial levan: physicochemical mediation and context-dependent functionality.

RSC advances·2026

Glycoalkaloids Affect the Animal Nervous System: A Review.

Journal of toxicology·2026

Microsphere-loaded dual-response in situ gel for enhanced ocular drug delivery.

Journal of pharmaceutical analysis·2026

Guaianolide-type sesquiterpenes from Rhaponticum repens (L.) Hidalgo with anti-ischemic stroke activity.

Bioorganic chemistry·2026

Total Synthesis of Nocarterphenyls A-B and 2-Dehydroxymethylnocarterphenyl A, Formal Synthesis of Nocarterphenyl D, and Biological Evaluation of Nocarterphenyls as α-Glucosidase Inhibitors.

The Journal of organic chemistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us